NOTE 10 – BORROWINGS

Federal Funds Purchased and Retail Repurchase Agreements

Federal funds purchased and retail repurchase agreements included the following at December 31, 2025 and 2024.

 

 

2025

 

 

2024

 

Federal funds purchased

 

$

 

 

$

 

Retail repurchase agreements

 

$

39,864

 

 

$

37,246

 

 

Securities sold under agreements to repurchase (retail repurchase agreements) consist of obligations of the Company to other parties. The obligations are secured by residential mortgage-backed securities held by the Company with a fair value of $41,481 and $45,249 at December 31, 2025 and 2024. The agreements are on a day-to-day basis and can be terminated on demand.

The following table presents the borrowing usage and interest rate information for federal funds purchased and retail repurchase agreements at and for the years ended December 31, 2025 and 2024.

 

 

2025

 

 

2024

 

Average daily balance during the period

 

$

41,479

 

 

$

39,791

 

Average interest rate during the period

 

 

1.77

%

 

 

1.89

%

Maximum month-end balance during the period

 

$

46,708

 

 

$

47,312

 

Weighted average interest rate at period-end

 

 

1.46

%

 

 

1.74

%

Federal Home Loan Bank advances

The Federal Home Loan Bank advances as of December 31, 2025, and 2024 were as follows.

 

 

2025

 

 

Weighted Average Rate

 

 

2024

 

 

Weighted Average Rate

 

 

Federal Home Loan Bank line of credit advances

 

$

200,000

 

 

 

3.89

%

 

$

78,073

 

 

 

4.57

%

 

Federal Home Loan Bank fixed-rate term advances

 

 

100,000

 

 

 

3.84

%

 

 

100,000

 

 

 

4.50

%

 

Total Federal Home Loan Bank advances

 

$

300,000

 

 

 

3.87

%

 

$

178,073

 

 

 

4.53

%

 

 

At December 31, 2025 and 2024, the Company had undisbursed advance commitments (letters of credit) with the Federal Home Loan Bank of $64,635 and $118,326. These letters of credit were obtained in lieu of pledging securities to secure public fund deposits that are over the FDIC insurance limit.

The advances, Mortgage Partnership Finance credit enhancement obligations and letters of credit were collateralized by certain qualifying loans of $932,939 at December 31, 2025, and qualifying loans of $885,128 and securities of $79,417 for a total of $964,545 at December 31, 2024. Based on this collateral and the Company’s holdings of Federal Home Loan Bank stock, the Company was eligible to borrow an additional $567,399 and $667,092 at December 31, 2025 and 2024.

Federal Reserve Bank Borrowings

At December 31, 2025 and 2024, the Company had a borrowing capacity of $1,863,782 and $648,183, for which the Company has pledged loans with an outstanding balance of $2,456,465 at December 31, 2025 and pledged loans with an outstanding balance of $852,957 and securities with a fair value of $9,070 at December 31, 2024. At December 31, 2025 and December 31, 2024 there were no outstanding borrowings under the Federal Reserve's Bank Term Funding Program.

Bank Stock Loan

The Company entered into an agreement with an unaffiliated financial institution and is secured by the Company’s stock in Equity Bank. The loan was renewed on February 10, 2023, with a new maturity date of February 10, 2024. With this renewal, the maximum borrowing amount remained at $25,000. Each note will bear interest at the greater of a variable interest rate equal to the prime rate published in the “Money Rates” section of The Wall Street Journal (or any generally recognized successor), floating daily, or a floor of 3.25%. Accrued interest and principal payments will be due quarterly with one final payment of unpaid principal and interest due at the end of the five-year term of each separate note. The Company is also required to pay an unused commitment fee in an amount equal to 20 basis points per annum on the unused portion of the maximum borrowing facility due on the maturity date of the renewal.

The loan was renewed and amended on February 10, 2024, with the same terms as the previous renewal and a new maturity date of February 10, 2025.

The loan was renewed and amended on February 10, 2025, with the same terms as the previous renewal and a new maturity date of February 10, 2026.

The loan was renewed and amended on February 10, 2026, with the same terms as the previous renewal and a new maturity date of February 10, 2027. The maximum borrowing amount at December 31, 2025, was $25,000.

There were no bank stock loan advances as of December 31, 2025, or December 31, 2024.

 

The terms of the borrowing facility require the Company and Equity Bank to maintain minimum capital ratios and other covenants. For the twelve months ended December 31, 2025, the Company was in compliance with all terms of the borrowing facility. For the twelve months ended December 31, 2024, the Company was in compliance with all terms of the borrowing facility.

Historical Timeline

Fiscal YearFiled
2025Mar 6, 2026Showing above
2024Mar 7, 2025
2023Mar 7, 2024
2022Mar 9, 2023
2021Mar 9, 2022
2020Mar 9, 2021
2019Mar 10, 2020
2018Mar 20, 2019
2017Mar 16, 2018
2016Mar 16, 2017
2015Mar 17, 2016

About Debt Disclosures

Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.

Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.